Concepts (185)
Concepts are derived automatically from a person's publications.
In this concept 'cloud', the sizes of the concepts are based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the same topic. The largest concepts are those that are most unique to this person.
- Administration, Intravenous
- Adult
- Age Factors
- Aged
- Aged, 80 and over
- Amides
- Antibodies, Bispecific
- Antibodies, Monoclonal
- Antibodies, Monoclonal, Humanized
- Antineoplastic Agents
- Antineoplastic Agents, Hormonal
- Antineoplastic Agents, Immunological
- Antineoplastic Combined Chemotherapy Protocols
- Antiviral Agents
- Aromatase Inhibitors
- Asymptomatic Diseases
- Australia
- Axilla
- Betacoronavirus
- Biomarkers, Tumor
- Biosimilar Pharmaceuticals
- Blood Platelets
- Body Mass Index
- Body Weight
- BRCA1 Protein
- BRCA2 Protein
- Breast Neoplasms
- Breast Neoplasms, Male
- Cancer Survivors
- Capecitabine
- Carcinoma, Ductal, Breast
- Carcinoma, Intraductal, Noninfiltrating
- Carcinoma, Lobular
- Case-Control Studies
- Cell-Derived Microparticles
- Central Venous Catheters
- Chemical and Drug Induced Liver Injury
- Chemotherapy, Adjuvant
- China
- Clinical Trials as Topic
- Combined Modality Therapy
- Comorbidity
- Continuity of Patient Care
- Coronavirus Infections
- Costs and Cost Analysis
- Cross Infection
- Cross-Over Studies
- Cytochrome P-450 Enzyme System
- Databases, Factual
- Decision Making
- Delivery of Health Care
- Developing Countries
- Diagnosis, Differential
- Disclosure
- Disease Management
- Disease-Free Survival
- DNA-Binding Proteins
- Double-Blind Method
- Drug Administration Schedule
- Drug Combinations
- Drug Costs
- Drug Interactions
- Drug Prescriptions
- Drug Resistance, Neoplasm
- Estradiol
- Europe
- Fanconi Anemia Complementation Group N Protein
- Fees, Pharmaceutical
- Female
- Fibrin Fibrinogen Degradation Products
- France
- General Surgery
- Genetic Counseling
- Genetic Predisposition to Disease
- Genetic Testing
- Germany
- Gestational Age
- Global Burden of Disease
- Global Health
- Gonadotropin-Releasing Hormone
- Guideline Adherence
- Health Care Surveys
- Health Priorities
- Health Services
- Health Services Needs and Demand
- Hereditary Breast and Ovarian Cancer Syndrome
- High-Throughput Nucleotide Sequencing
- Histone Deacetylase Inhibitors
- Hospitalization
- Humans
- Hydroxychloroquine
- Hygiene
- Immunization Programs
| - Immunohistochemistry
- Incidence
- Infection Control
- Influenza, Human
- Injection Site Reaction
- Injections, Intravenous
- Injections, Subcutaneous
- Insurance Claim Review
- Italy
- Kaplan-Meier Estimate
- Ki-67 Antigen
- Kidney Diseases
- Long QT Syndrome
- Lopinavir
- Lymphatic Metastasis
- Male
- Mass Screening
- Mastectomy
- Maytansine
- Medical Oncology
- Membrane Transport Proteins
- Middle Aged
- Molecular Targeted Therapy
- Needs Assessment
- Neoadjuvant Therapy
- Neoplasm Metastasis
- Neoplasm Recurrence, Local
- Neoplasms
- Neoplastic Stem Cells
- New Zealand
- Ovarian Neoplasms
- Ovariectomy
- Pandemics
- Paris
- Patient Preference
- Patient Selection
- Personal Space
- Pneumonia, Viral
- Poly(ADP-ribose) Polymerase Inhibitors
- Postmenopause
- Postpartum Period
- Poverty
- Practice Guidelines as Topic
- Precision Medicine
- Pregnancy
- Pregnancy Complications, Neoplastic
- Pregnancy Outcome
- Premenopause
- Prognosis
- Propensity Score
- Prospective Studies
- Proteasome Inhibitors
- Protein Domains
- Protein Kinase Inhibitors
- Public Health
- Pyrazines
- Quality of Life
- Quarantine
- Quinazolines
- Radiation Oncology
- Randomized Controlled Trials as Topic
- Receptor, ErbB-2
- Receptors, Estrogen
- Receptors, Progesterone
- Retrospective Studies
- Risk
- Risk Assessment
- Risk Factors
- Ritonavir
- RNA, Messenger
- Salpingo-oophorectomy
- Sentinel Lymph Node Biopsy
- Sequence Analysis, DNA
- Seroconversion
- Social Isolation
- Societies, Medical
- Spain
- Stomach Neoplasms
- Survival Analysis
- Survival Rate
- Symptom Assessment
- Tamoxifen
- Thrombin
- Thromboembolism
- Thrombophilia
- Time Factors
- Trastuzumab
- Treatment Outcome
- Ultrasonography, Doppler
- United States
- Vaccines
- Young Adult
|
Gligorov's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(185)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(190)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_